{"ticker": {"uuid": "e6d6f6cd-b116-4f7d-84da-83e4b1e4bdd6", "symbol": "LFMD", "name": "LifeMD Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Health Information Services"}, "articles": [{"title": "LifeMD Rings the Nasdaq Stock Market Closing Bell", "summary": "LifeMD, a national provider of virtual healthcare and pharmacy services, celebrated by ringing the Nasdaq Stock Market Closing Bell. Co-Founders Stefan Galluppi and Justin Schreiber represented the company at the Nasdaq MarketSite in Times Square for the occasion. The event highl", "url": "https://www.nasdaq.com/videos/lifemd-rings-nasdaq-stock-market-closing-bell", "source_name": "Nasdaq", "published_at": "2026-07-09T20:13:23", "published_display": "09 Jul 2026 20:13", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Federated Hermes reports 2.75M-share stake in LifeMD (LFMD)", "summary": "Federated Hermes, Inc. has reported a shared beneficial ownership of 2,747,655 shares of LifeMD common stock (LFMD), representing 5.68% of the class as of June 30, 2026. The Schedule 13G filing indicates shared voting and dispositive power among Federated Hermes, the Voting Share", "url": "https://www.stocktitan.net/sec-filings/LFMD/schedule-13g-life-md-inc-passive-investment-disclosure-5-f7a0342959da.html", "source_name": "Stock Titan", "published_at": "2026-07-08T12:11:06", "published_display": "08 Jul 2026 12:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "B.Riley reiterates LifeMD stock Buy rating on telehealth expansion", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOeEY2MTI1NzVwV2xfYnkwVnlHZWVKcGF4aHJveldHd2NEOEFqVnlySFpJRFFBQ3RzMDRkbXU1SWMwVVhSTXlwd1A4ZVhnZE5sUzRHWGhGLWlJQmI1VEx3Q3RubllPd2NJckVYTUJrdUQxQkFwb3hWOUoxVU45UUtGT2Fmc2hBdWZoUC1VUXdEa1JFTE5hQUFyb2lxclhsdmtYRE9vQ0MtQVg0d05QNW9YVThERllkS01MbGFLRnVRTkFpcGs?oc=5", "source_name": "Investing.com", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of LifeMD, Inc. \u2013 NASDAQ:LFMD", "summary": "This page displays the \"Price to book forward\" financial metric for LifeMD, Inc. (NASDAQ:LFMD). The content includes general financial information for the company as found on TradingView, along with various navigation and information sections typical of such a platform.", "url": "https://www.tradingview.com/symbols/NASDAQ-LFMD/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T04:10:49", "published_display": "29 Jun 2026 04:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LFMD SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno", "summary": "Bronstein, Gewirtz and Grossman, LLC has announced a shareholder alert regarding LifeMD, Inc. (NASDAQ: LFMD). A class action lawsuit has been filed on behalf of investors who purchased LifeMD securities between May 7, 2025, and August 5, 2025, alleging that the company made false", "url": "https://natlawreview.com/press-releases/lfmd-shareholder-alert-bronstein-gewirtz-and-grossman-llc-announces-lifemd-1", "source_name": "The National Law Review", "published_at": "2026-06-29T02:39:57", "published_display": "29 Jun 2026 02:39", "sentiment": "negative", "sentiment_pct": 24, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of LifeMD, Inc. \u2013 NASDAQ:LFMD", "summary": "This article provides financial information for LifeMD, Inc. (NASDAQ: LFMD), specifically focusing on its enterprise value to EBIT forward. The content appears to be an excerpt from a financial data platform, likely TradingView, presenting a snapshot of the company's financial me", "url": "https://www.tradingview.com/symbols/NASDAQ-LFMD/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T03:39:12", "published_display": "27 Jun 2026 03:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock", "summary": "LifeMD, Inc. (Nasdaq: LFMD) announced that its Board of Directors authorized a cash dividend of $0.5546875 per share for holders of its 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP). The dividend will be paid on July 15, 2026, to shareholders of record as o", "url": "https://finance.yahoo.com/healthcare/articles/lifemd-declares-quarterly-dividend-series-120000045.html", "source_name": "Market source", "published_at": "2026-06-26T17:39:29", "published_display": "26 Jun 2026 17:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of LifeMD, Inc. \u2013 NASDAQ:LFMD", "summary": "This article provides financial data for LifeMD, Inc. (NASDAQ: LFMD), specifically its price-to-sales forward ratio. The content is presented in a data-table format, indicating periods, values, and percentage changes. The information is provided by TradingView, with data sourced ", "url": "https://www.tradingview.com/symbols/NASDAQ-LFMD/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T03:09:44", "published_display": "26 Jun 2026 03:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of LifeMD, Inc. \u2013 NASDAQ:LFMD", "summary": "This page provides financial information for LifeMD, Inc. (NASDAQ:LFMD) on TradingView, specifically focusing on its enterprise value to revenue forward metric. The content indicates that the market is currently closed with no trades. It also details the various data sources used", "url": "https://www.tradingview.com/symbols/NASDAQ-LFMD/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T19:41:23", "published_display": "25 Jun 2026 19:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED\u00ae (testosterone enanthate) Injection", "summary": "LifeMD, Inc. has announced an exclusive co-marketing collaboration with Halozyme's subsidiary, Antares Pharma, Inc., to launch a direct-to-patient self-pay program for XYOSTED\u00ae (testosterone enanthate) injection. This program, launching in July 2026 across 37 states, aims to prov", "url": "https://finance.yahoo.com/healthcare/articles/lifemd-announces-exclusive-collaboration-launch-120000826.html", "source_name": "Market source", "published_at": "2026-06-25T14:41:04", "published_display": "25 Jun 2026 14:41", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIFEMD INC PFD SER A 8.875% To Go Ex-Dividend On July 2nd, 2026 With 0.55469 USD Dividend Per Share", "summary": "LifeMD Inc. Preferred Series A 8.875% is scheduled to go ex-dividend on July 2nd, 2026. Shareholders will receive a dividend of 0.55469 USD per share. This information is crucial for investors tracking dividend income.", "url": "https://news.futunn.com/en/post/74983037/lifemd-inc-pfd-ser-a-8-875-to-go-ex", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-06-24T15:11:30", "published_display": "24 Jun 2026 15:11", "sentiment": "positive", "sentiment_pct": 67, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD (Nasdaq: LFMD) inks exclusive telehealth collaboration for XYOSTED self-pay program", "summary": "LifeMD (Nasdaq: LFMD) has announced an exclusive strategic co-marketing collaboration with Antares Pharma, a Halozyme subsidiary, to launch a direct-to-patient self-pay program for XYOSTED, an FDA-approved once-weekly subcutaneous testosterone auto-injector. This program, set to ", "url": "https://www.stocktitan.net/sec-filings/LFMD/8-k-life-md-inc-reports-material-event-f7e6fe315dc1.html", "source_name": "Stock Titan", "published_at": "2026-06-22T12:39:26", "published_display": "22 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD to Launch Exclusive XYOSTED Self-Pay Telehealth Program in July across 37 States", "summary": "LifeMD announced an exclusive telehealth co-marketing collaboration with Antares Pharma to launch a direct-to-patient self-pay XYOSTED program in July 2026. This program will initially be available in 37 states, with LifeMD's affiliated medical group evaluating patients and its p", "url": "https://www.tradingview.com/news/tradingview:5ba6b6ad36146:0-lifemd-to-launch-exclusive-xyosted-self-pay-telehealth-program-in-july-across-37-states/", "source_name": "TradingView", "published_at": "2026-06-22T12:39:25", "published_display": "22 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 94, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD Announces Exclusive Collaboration to Launch", "summary": "LifeMD, Inc. has announced an exclusive co-marketing collaboration with Halozyme\u2019s Antares Pharma for a direct-to-patient self-pay program for XYOSTED\u00ae (testosterone enanthate) injection. This program, launching in July 2026 in 37 states, aims to provide convenient and transparen", "url": "https://www.globenewswire.com/news-release/2026/06/22/3315216/6480/en/lifemd-announces-exclusive-collaboration-to-launch-direct-to-patient-self-pay-program-for-xyosted-testosterone-enanthate-injection.html", "source_name": "GlobeNewswire", "published_at": "2026-06-22T10:40:20", "published_display": "22 Jun 2026 10:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD, Halozyme link up to sell testosterone therapy online", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQRkthaVVibmxVd3VmTVR6MnJ5eEpPTUgxMm53SFhZVkNsd3lsN3NzbVpMVVlyc0F3RGpXM3hmNU1ESWdXdDh5ZWdBSlNOVmpQQURqZWdjUnJncWNRMkE1Nlp4d1dyZ19tVHpQcm01X2hSTktUZzF4Y1VnTnFhakJJSUNLd3FsSUI4VWt0enNsRXY2djk2aHB1Q3F4ZWFhT2lCSHR0MWQyeDFwbWRoLU81QXdNak5BLUU?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD Inc (LFMD) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of LifeMD Inc's (LFMD) dividend and stock split history. It notes that the company has distributed $0.00 in dividends over the past five years and has no recorded stock split data. The page also presents current stock performance metrics and mark", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lfmd/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T01:40:05", "published_display": "18 Jun 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD Inc (LFMD) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for LifeMD Inc (LFMD), detailing its current earnings forecast score, analyst ratings, and price targets. As of June 17, 2026, the company has an earnings forecast score of 8.25 and an average price target of $8.50 from 8 analysts, most ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lfmd/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T20:40:05", "published_display": "17 Jun 2026 20:40", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD, Inc. (LFMD) reports Q1 loss, tops revenue estimates", "summary": "LifeMD, Inc. (LFMD) reported a narrower-than-expected loss for the first quarter, with an adjusted loss of $0.06 per share. The company also exceeded revenue estimates, generating $37.56 million compared to the anticipated $37.16 million. Despite the revenue beat, the company's n", "url": "https://www.msn.com/en-us/money/other/lifemd-inc-lfmd-reports-q1-loss-tops-revenue-estimates/ar-AA22yPNr?ocid=BingNewsVerp", "source_name": "MSN", "published_at": "2026-06-11T18:39:45", "published_display": "11 Jun 2026 18:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Understanding Momentum Shifts in (LFMDP)", "summary": "This article provides an in-depth analysis of Lifemd Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (NASDAQ: LFMDP), highlighting a neutral sentiment across all time horizons. It presents three distinct AI-generated trading strategies\u2014position trading, momentum breakou", "url": "https://news.stocktradersdaily.com/news_release/1/Understanding_Momentum_Shifts_in_LFMDP_061026032002_1781119202.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-10T15:20:00", "published_display": "10 Jun 2026 15:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD: A Growing Healthcare Tech Stock, As Q1 Results Confirm Patient Demand", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPYjZTemNEbEdKQ0ZmOE1TaFE5bTFReUV5SmlPazBuZUZGdHVGLW41ZTBvMHE4cDVPRFZyVFEwMGItN2ppMkhFWUVnZ2xsQjRvamRaVjFOSE80NlMyNGlyaVdXc0xFQmVicG5YbkJuUUhiN3hqQW50bVVVYWJFckY1WGNjaF9rR1B4TVluNzNJc3pwUUZWdVBucEIxb1czaGZWeGFtNy0tUjlvM1Vpa2J6YU5KZnM3dTJsNHpmUQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Story Is Evolving For LifeMD (LFMD) With An Unchanged Fair Value View", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQbm5aTEdkWUlhT3ZkbXh0SGpxZVV6MEZ5ZlZiTWRmR2d3RDk2ZGpJWDBSeXhDWXNSY0ktSnBoc1JUUnlJWVUxbVM3anhEVERud01uc200aFZvU0xWQU9lem8tQmZnUnZiRU1GenI3Zlg5WVdjcWlENVV5azVwR0pjLUVCV1RQYzBjOEktLXY4NWNwNENPcEI2R3haaWJGNG9mOG9J?oc=5", "source_name": "Market source", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD (LFMD) CTO Sripad Umesh submits initial Form 3 filing", "summary": "LifeMD, Inc.'s Chief Technology Officer, Sripad Umesh, has submitted his initial Form 3 filing, an SEC document reporting beneficial ownership of securities. The filing identifies Umesh as an officer but not a ten percent owner of the company, and it states that there were no sha", "url": "https://www.stocktitan.net/sec-filings/LFMD/form-3-life-md-inc-initial-statement-of-beneficial-ownership-f23d6fe6bd3f.html", "source_name": "Stock Titan", "published_at": "2026-06-04T01:40:17", "published_display": "04 Jun 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD (LFMD) CTO receives 75,000-share time-vested stock grant", "summary": "LifeMD, Inc.'s Chief Technology Officer, Sripad Umesh, received a grant of 75,000 shares of common stock as compensation, indicating a neutral impact and sentiment. These shares are restricted stock units that will vest in three installments over three years: 25,000 units on June", "url": "https://www.stocktitan.net/sec-filings/LFMD/form-4-life-md-inc-insider-trading-activity-e55ab58d4586.html", "source_name": "Stock Titan", "published_at": "2026-06-04T01:40:17", "published_display": "04 Jun 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Press Release: LifeMD Appoints Umesh Sripad as Chief Technology Officer", "summary": "LifeMD has announced the appointment of Umesh Sripad as its new Chief Technology Officer. Sripad brings extensive experience from his previous executive roles at companies like Best Buy and Amazon, where he led significant technological advancements and strategic initiatives. His", "url": "https://www.moomoo.com/hans/news/post/70862237/press-release-lifemd-appoints-umesh-sripad-as-chief-technology-officer", "source_name": "Moomoo", "published_at": "2026-06-02T03:39:39", "published_display": "02 Jun 2026 03:39", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD Appoints Umesh Sripad as Chief Technology Officer", "summary": "LifeMD, Inc. has appointed Umesh Sripad as its new Chief Technology Officer, effective immediately. Mr. Sripad brings over two decades of experience in digital transformation and will be responsible for leading LifeMD's technology strategy, AI enablement, cybersecurity, and scala", "url": "https://www.globenewswire.com/news-release/2026/06/01/3304337/6480/en/lifemd-appoints-umesh-sripad-as-chief-technology-officer.html", "source_name": "GlobeNewswire", "published_at": "2026-06-02T02:40:17", "published_display": "02 Jun 2026 02:40", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD Names Umesh Sripad as Chief Technology Officer", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/lifemd-names-umesh-sripad-chief-132319380.html", "source_name": "MT Newswires", "published_at": "2026-06-01T13:23:19+00:00", "published_display": "01 Jun 2026 13:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ex-IKEA digital chief to lead AI, cybersecurity at telehealth LifeMD", "summary": "LifeMD (Nasdaq: LFMD) has appointed Umesh Sripad as Chief Technology Officer to spearhead the company's technology strategy, AI initiatives, cybersecurity, and data infrastructure as it expands its direct-to-patient telehealth platform. Sripad, who previously held leadership role", "url": "https://www.stocktitan.net/news/LFMD/life-md-appoints-umesh-sripad-as-chief-technology-wxsplvc3kmdo.html", "source_name": "Stock Titan", "published_at": "2026-06-01T12:09:51", "published_display": "01 Jun 2026 12:09", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD to Participate in Upcoming Investor Conferences", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/lifemd-participate-upcoming-investor-conferences-120000967.html", "source_name": "GlobeNewswire", "published_at": "2026-05-15T12:00:00+00:00", "published_display": "15 May 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD, Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/41e181b8-b18a-3255-9720-0df6d7bd192b/lifemd%2C-inc.-q1-2026-earnings.html", "source_name": "Moby", "published_at": "2026-05-07T12:30:00+00:00", "published_display": "07 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD Q1 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/13172cbc-f2ee-3d92-be99-a212f1217b26/lifemd-q1-earnings-call.html", "source_name": "MarketBeat", "published_at": "2026-05-07T02:16:46+00:00", "published_display": "07 May 2026 02:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD adds 42,000 subscribers; women\u2019s sign-ups jump 657%", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxOenBXcjRsOFI3WEJOWGZ6WGZZZXFSX29GY0w5ajlnc3EtNHQ0SzNsRFVMeGc1cUx5V25WTmVqcE9xbzNoTmJGVkZNbElyYTdFRy1NWU91Snh0a3BxbjdDeklFU183TXlHZ2pvWnlXczFRLWlDaWRfdDVBdW5oN2h6NTZ0OTFoamhCMnl2WDlNZTZMWWM?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The LifeMD (LFMD) Story Is Shifting Around GLP-1 Growth And 2026 Expectations", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQazhpZlNhSjNqaU9LeFd4b251S1lOOGtRc3RuVEUwN1NRM0liNnh2YTdyNU9jREp5T0p6S29UWTVFTFFwRlVLNmNSSkFXOVZpUjNhWVJldFRzNjlaZ1VTeUpLRWZIWWdEY3huQ015dnUyWDdjUXhWZ1RZRzQ5cUFLYUxRaXhNVEszTTZqc1RMTWVqWnVaM2xRcmFvTVFMY0E?oc=5", "source_name": "Market source", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "After the bell May 6: LifeMD sets Q1 results call for 4:30 p.m. ET", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQWnlfSTBIUFdzT0lpbUwtcmU3WTdTa0NXZjZCSEdWWmtlYll3ZGRITDZxNVdqMDdCX052cHV1V2hHOWE1T19lLUFHdE9nVzJ1TnhDY09BdFd6WGlmQVBSSE5nQzhpa1NacDBSWDdYVGNxZzZuakxGc0d0SGllRUZ1QkQyQUpudzJjem9nTGdWcGQ2M1VzTGJ1ZFRGM3lVcjdROXcyRWVpbHFWd2V6LS1oUEVGbHozd2c?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD (LFMD) Soars 23.7%: Is Further Upside Left in the Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNdVowRzMxQW5hTDBWRV9xUEZWemRsV2Vsc0xPSTZvcVRTWlBVOFE0ZE9hb25oeERJclpaRkZDQmpFMmN5dmFUd2tSYjQ3VVVCZUJvVy1UZEFiOHUzX2VUajk0TUhzSlZZeURVb0FUenFuVmNjWGQ1UEFJeksyajQ2aDRUSTRxUEI0Y0lMU0RLVUM?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The LifeMD (LFMD) Story Is Shifting Around GLP-1 Growth Plans And 2026 Expectations", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQcXNWV0VIekNnVTllc2hBU2xOUHdsTDdmR3dFWC1aTVhxN0FKNTIxNkRJWmRUS3h6WUs0OEY0OTNoWVhoTDNJYjBnNFlYX2hzSkxLSVVnbWpyLU4yeHdBQkhOR1YxZmNBTld0T2hZOHRCbnJrMjk0WDlQSVVRX0hHaVFuOUhyZ3o3ZzZlUUc4Rm9hUElVME1INmpuMlpOTzQ?oc=5", "source_name": "Market source", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The LifeMD (LFMD) Story Is Shifting On GLP\u20111 Growth And Higher 2026 Targets", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxORHdYU0hydjJrdTNxMVdTSTcwVW9TbHVxdDc1Y005UlZPdHcxUy1QTjJzQkx4M2VxQ3Z4TVQ1a3Fwdm1PUW5ZOWEzUm9uRlhVUjdjZ1hLYmlaR0lNdlhYMDRXdVZhMUNnVGJkTUdJUzNmcHBiLTQwbDVKWk53QWVnSzk1d1NLbXREUlBjZUFWOVB0RFhieG5zdUxPNA?oc=5", "source_name": "Market source", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD (LFMD) Is Up 32.7% After Returning To Profitability And Expanding GLP\u20111 Telehealth Offerings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-14T07:00:00+00:00", "published_display": "14 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At LifeMD (LFMD) Valuation After Profitability Return And 2026 Growth Guidance", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxPZG13a05hTWJpZ0Y0dk5Wa2tjNWMtaXhCQlFOckEzZi1PaVF6TThGSG9xVElyZVY4Z2J6VERPMGpyZWpyaS1LLUpFUzRqQ1JycjBvVHJXVEhzRHdqbWhHWXFRMGFXY3dlZGlBa2gzUGx1VzRkdFFXRVBFSE9oSGRRMjdlR1Ixb2pRNFBkV2Yzaw?oc=5", "source_name": "Market source", "published_at": "2026-03-13T07:00:00+00:00", "published_display": "13 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD (LFMD) Valuation Check After Earnings Beat Guidance Update And Wegovy Partnership", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxOZkp0ZHJHTjVtQW1lZm9iUW1Halh0aHlCR0JBQWJqVjlIY3RmR1ItMUxOR1E2QzdDX1VuamFlY0hCbWZ2Vm1DMzlkblBsbW5HbHB1aktkLXNBYi1FTlFPbUxpNWJDd2hwSkFjTThBTDRPbUMyaks1SmZ3VGtoNTBGU3VabGZHWE5kbXprRDhicjVLTWtNTnQzOGNmRnh1MzFZdGtLZXNfZ0RJcEVaV2RBRVB1X0N4NDdFMWg1UGtHbVhTR002dXfSAcsBQVVfeXFMTjZTdG12TE5NMXpXN1B1dS1BazBQWWVpdmtaaVZKYURybEl3eVlRRmdUeWp1aEVYYVNrTDBBdWZrNGVTVXJYNWhiNUxGNnZZSGFWdEhKYUNQcHBCWjJLdlFKWHBSNWU3XzhKM1UwVXRWVE5nNHY3RmhQQ0dpaks5MHppQnJUVXFiZms3SHU2WHpUV2ktb1FvUG1Vd1VTRTdxWmVfbW9YRU1IUm5wSDVBZ3pYQ2pLR0I0NE4tMEdDOFptUV9STVotcUhNWm8?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD (LFMD) Trailing Losses Narrow To US$14.6m Challenging Bearish Profitability Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What Do LifeMD's Q4 2025 Results Really Tell Us", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxPamJtaUgyZ3FlZU5qQXJzYTBVQlZ6cXBXdzRxZTlzeEhjQmRvZ1lka3MtcUUwc1Z2R3lxZHFSWEZrRmdPM0dCdUhJOWxQb0hHLWs3MG1qS3lERTRkTUNVbHpJalJscEl6Ullqcm5uU2lxdW1xb1E2Mnp2cmI3NUVaS1Q1cWhrWXBTR3c?oc=5", "source_name": "Kavout | AI", "published_at": "2026-03-09T07:00:00+00:00", "published_display": "09 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIFEMD ($LFMD) Releases Q4 2025 Earnings, Stock Rises | LFMD Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNTHNsRmxiWTBmTmlVRkJKd0pvbVM2ZnZneExZdEZSbXRuLVl3Vml5NExqdndUTmtfd29DTU5USWZiMkZrTFdtUjdOSTBzcWVLbDRLOTRMOWJhVzQ1dDJURl91YmdBQ3lXTDc1eUg1R0VSMFdWa2tkSHVzempIUG5iRVY3OEdmeEZ0TURvYjJmM045azJsUWUyZUd3?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-03-09T07:00:00+00:00", "published_display": "09 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD, Inc. (LFMD) Reports Q4 Loss, Tops Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE43dTRFcjlVQ2pCYUJNS05MZlN3aV96clA1dzB4WXhuNkVRUHpiYUFYa0ZOV2l3QWZfUlNZQ2J2dzFTem1XYXROUDdIVW1Qek5MbTNWeGNka1hSVnlBUGVFLU5BTG56alBORzBkbm1hbi1aSjhNRHRLRmdBSEc?oc=5", "source_name": "Market source", "published_at": "2026-03-09T07:00:00+00:00", "published_display": "09 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Investors Shouldn't Be Surprised By LifeMD, Inc.'s (NASDAQ:LFMD) 31% Share Price Plunge", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-12T08:00:00+00:00", "published_display": "12 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD, Inc. Common Stock (LFMD) Stock Price Today & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE9hWHdDM2ZjSWJfM0JYTzZ1LTlMUkJaZWRRd0NGNG40Vl9pcEFfd3RKZGVGeXN2bWxmeGMtanNzQmlsaW1Ub2FCQU4zWFpQaEFMSzdnY3h2OA?oc=5", "source_name": "Gotrade", "published_at": "2026-01-13T02:37:55+00:00", "published_display": "13 Jan 2026 02:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why LifeMD (LFMD) Is Up 15.2% After Securing Credit Line And Adding Oral Wegovy Access", "summary": "", "url": "https://news.google.com/rss/articles/CBMidEFVX3lxTE1rcUt0R1V0Q0ZidGJFWHFFY2RrR1VuaUFKQnk0M25XM2dkSW1fajZDNmxqUXlweFVvWDdWVl9FZlRrblR4R1BFSm95NmxUSGdqeG5EUFdUUUpmUGcxUTV3YnZBVThtQ1lTUXR5R2lIU0o1YUM3?oc=5", "source_name": "Market source", "published_at": "2026-01-08T08:00:00+00:00", "published_display": "08 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD (LFMD): Valuation in Focus After Earnings Miss, Guidance Cut, and Telehealth Shift", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxPVy1fXzJCakcxMlRKcl9sQndHZkRzcFVlejJQMURiVEtUeEhyb1dBWk9vOVB0VWxYcGlBTHU2LTZUcHZrQUtHQkx5V003TFhpWlZvOWVBdGxXcFZyWG54UFVNaFB5SGc3b1pPNTVObzI4emFXZHhRWW9XU3h2Y1BQeU9pU1lMLXdZbGc?oc=5", "source_name": "Market source", "published_at": "2025-11-20T08:00:00+00:00", "published_display": "20 Nov 2025 08:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD, Inc.'s (NASDAQ:LFMD) Path To Profitability", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-10-11T07:00:00+00:00", "published_display": "11 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Insider Has Just Sold Shares In LifeMD", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-09-15T07:00:00+00:00", "published_display": "15 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD, Inc.'s (NASDAQ:LFMD) market cap dropped US$56m last week; individual investors who hold 44% were hit as were institutions", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-07-12T07:00:00+00:00", "published_display": "12 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "LifeMD Rings the Nasdaq Stock Market Closing Bell", "summary": "LifeMD, a national provider of virtual healthcare and pharmacy services, celebrated by ringing the Nasdaq Stock Market Closing Bell. Co-Founders Stefan Galluppi and Justin Schreiber represented the company at the Nasdaq MarketSite in Times Square for the occasion. The event highl", "url": "https://www.nasdaq.com/videos/lifemd-rings-nasdaq-stock-market-closing-bell", "source_name": "Nasdaq", "published_at": "2026-07-09T20:13:23", "published_display": "09 Jul 2026 20:13", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Federated Hermes reports 2.75M-share stake in LifeMD (LFMD)", "summary": "Federated Hermes, Inc. has reported a shared beneficial ownership of 2,747,655 shares of LifeMD common stock (LFMD), representing 5.68% of the class as of June 30, 2026. The Schedule 13G filing indicates shared voting and dispositive power among Federated Hermes, the Voting Share", "url": "https://www.stocktitan.net/sec-filings/LFMD/schedule-13g-life-md-inc-passive-investment-disclosure-5-f7a0342959da.html", "source_name": "Stock Titan", "published_at": "2026-07-08T12:11:06", "published_display": "08 Jul 2026 12:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "B.Riley reiterates LifeMD stock Buy rating on telehealth expansion", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOeEY2MTI1NzVwV2xfYnkwVnlHZWVKcGF4aHJveldHd2NEOEFqVnlySFpJRFFBQ3RzMDRkbXU1SWMwVVhSTXlwd1A4ZVhnZE5sUzRHWGhGLWlJQmI1VEx3Q3RubllPd2NJckVYTUJrdUQxQkFwb3hWOUoxVU45UUtGT2Fmc2hBdWZoUC1VUXdEa1JFTE5hQUFyb2lxclhsdmtYRE9vQ0MtQVg0d05QNW9YVThERllkS01MbGFLRnVRTkFpcGs?oc=5", "source_name": "Investing.com", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of LifeMD, Inc. \u2013 NASDAQ:LFMD", "summary": "This page displays the \"Price to book forward\" financial metric for LifeMD, Inc. (NASDAQ:LFMD). The content includes general financial information for the company as found on TradingView, along with various navigation and information sections typical of such a platform.", "url": "https://www.tradingview.com/symbols/NASDAQ-LFMD/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T04:10:49", "published_display": "29 Jun 2026 04:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LFMD SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno", "summary": "Bronstein, Gewirtz and Grossman, LLC has announced a shareholder alert regarding LifeMD, Inc. (NASDAQ: LFMD). A class action lawsuit has been filed on behalf of investors who purchased LifeMD securities between May 7, 2025, and August 5, 2025, alleging that the company made false", "url": "https://natlawreview.com/press-releases/lfmd-shareholder-alert-bronstein-gewirtz-and-grossman-llc-announces-lifemd-1", "source_name": "The National Law Review", "published_at": "2026-06-29T02:39:57", "published_display": "29 Jun 2026 02:39", "sentiment": "negative", "sentiment_pct": 24, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of LifeMD, Inc. \u2013 NASDAQ:LFMD", "summary": "This article provides financial information for LifeMD, Inc. (NASDAQ: LFMD), specifically focusing on its enterprise value to EBIT forward. The content appears to be an excerpt from a financial data platform, likely TradingView, presenting a snapshot of the company's financial me", "url": "https://www.tradingview.com/symbols/NASDAQ-LFMD/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T03:39:12", "published_display": "27 Jun 2026 03:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock", "summary": "LifeMD, Inc. (Nasdaq: LFMD) announced that its Board of Directors authorized a cash dividend of $0.5546875 per share for holders of its 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP). The dividend will be paid on July 15, 2026, to shareholders of record as o", "url": "https://finance.yahoo.com/healthcare/articles/lifemd-declares-quarterly-dividend-series-120000045.html", "source_name": "Market source", "published_at": "2026-06-26T17:39:29", "published_display": "26 Jun 2026 17:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of LifeMD, Inc. \u2013 NASDAQ:LFMD", "summary": "This article provides financial data for LifeMD, Inc. (NASDAQ: LFMD), specifically its price-to-sales forward ratio. The content is presented in a data-table format, indicating periods, values, and percentage changes. The information is provided by TradingView, with data sourced ", "url": "https://www.tradingview.com/symbols/NASDAQ-LFMD/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T03:09:44", "published_display": "26 Jun 2026 03:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of LifeMD, Inc. \u2013 NASDAQ:LFMD", "summary": "This page provides financial information for LifeMD, Inc. (NASDAQ:LFMD) on TradingView, specifically focusing on its enterprise value to revenue forward metric. The content indicates that the market is currently closed with no trades. It also details the various data sources used", "url": "https://www.tradingview.com/symbols/NASDAQ-LFMD/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T19:41:23", "published_display": "25 Jun 2026 19:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED\u00ae (testosterone enanthate) Injection", "summary": "LifeMD, Inc. has announced an exclusive co-marketing collaboration with Halozyme's subsidiary, Antares Pharma, Inc., to launch a direct-to-patient self-pay program for XYOSTED\u00ae (testosterone enanthate) injection. This program, launching in July 2026 across 37 states, aims to prov", "url": "https://finance.yahoo.com/healthcare/articles/lifemd-announces-exclusive-collaboration-launch-120000826.html", "source_name": "Market source", "published_at": "2026-06-25T14:41:04", "published_display": "25 Jun 2026 14:41", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIFEMD INC PFD SER A 8.875% To Go Ex-Dividend On July 2nd, 2026 With 0.55469 USD Dividend Per Share", "summary": "LifeMD Inc. Preferred Series A 8.875% is scheduled to go ex-dividend on July 2nd, 2026. Shareholders will receive a dividend of 0.55469 USD per share. This information is crucial for investors tracking dividend income.", "url": "https://news.futunn.com/en/post/74983037/lifemd-inc-pfd-ser-a-8-875-to-go-ex", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-06-24T15:11:30", "published_display": "24 Jun 2026 15:11", "sentiment": "positive", "sentiment_pct": 67, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD (Nasdaq: LFMD) inks exclusive telehealth collaboration for XYOSTED self-pay program", "summary": "LifeMD (Nasdaq: LFMD) has announced an exclusive strategic co-marketing collaboration with Antares Pharma, a Halozyme subsidiary, to launch a direct-to-patient self-pay program for XYOSTED, an FDA-approved once-weekly subcutaneous testosterone auto-injector. This program, set to ", "url": "https://www.stocktitan.net/sec-filings/LFMD/8-k-life-md-inc-reports-material-event-f7e6fe315dc1.html", "source_name": "Stock Titan", "published_at": "2026-06-22T12:39:26", "published_display": "22 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD to Launch Exclusive XYOSTED Self-Pay Telehealth Program in July across 37 States", "summary": "LifeMD announced an exclusive telehealth co-marketing collaboration with Antares Pharma to launch a direct-to-patient self-pay XYOSTED program in July 2026. This program will initially be available in 37 states, with LifeMD's affiliated medical group evaluating patients and its p", "url": "https://www.tradingview.com/news/tradingview:5ba6b6ad36146:0-lifemd-to-launch-exclusive-xyosted-self-pay-telehealth-program-in-july-across-37-states/", "source_name": "TradingView", "published_at": "2026-06-22T12:39:25", "published_display": "22 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 94, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD Announces Exclusive Collaboration to Launch", "summary": "LifeMD, Inc. has announced an exclusive co-marketing collaboration with Halozyme\u2019s Antares Pharma for a direct-to-patient self-pay program for XYOSTED\u00ae (testosterone enanthate) injection. This program, launching in July 2026 in 37 states, aims to provide convenient and transparen", "url": "https://www.globenewswire.com/news-release/2026/06/22/3315216/6480/en/lifemd-announces-exclusive-collaboration-to-launch-direct-to-patient-self-pay-program-for-xyosted-testosterone-enanthate-injection.html", "source_name": "GlobeNewswire", "published_at": "2026-06-22T10:40:20", "published_display": "22 Jun 2026 10:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD, Halozyme link up to sell testosterone therapy online", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQRkthaVVibmxVd3VmTVR6MnJ5eEpPTUgxMm53SFhZVkNsd3lsN3NzbVpMVVlyc0F3RGpXM3hmNU1ESWdXdDh5ZWdBSlNOVmpQQURqZWdjUnJncWNRMkE1Nlp4d1dyZ19tVHpQcm01X2hSTktUZzF4Y1VnTnFhakJJSUNLd3FsSUI4VWt0enNsRXY2djk2aHB1Q3F4ZWFhT2lCSHR0MWQyeDFwbWRoLU81QXdNak5BLUU?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD Inc (LFMD) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of LifeMD Inc's (LFMD) dividend and stock split history. It notes that the company has distributed $0.00 in dividends over the past five years and has no recorded stock split data. The page also presents current stock performance metrics and mark", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lfmd/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T01:40:05", "published_display": "18 Jun 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD Inc (LFMD) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for LifeMD Inc (LFMD), detailing its current earnings forecast score, analyst ratings, and price targets. As of June 17, 2026, the company has an earnings forecast score of 8.25 and an average price target of $8.50 from 8 analysts, most ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lfmd/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T20:40:05", "published_display": "17 Jun 2026 20:40", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD, Inc. (LFMD) reports Q1 loss, tops revenue estimates", "summary": "LifeMD, Inc. (LFMD) reported a narrower-than-expected loss for the first quarter, with an adjusted loss of $0.06 per share. The company also exceeded revenue estimates, generating $37.56 million compared to the anticipated $37.16 million. Despite the revenue beat, the company's n", "url": "https://www.msn.com/en-us/money/other/lifemd-inc-lfmd-reports-q1-loss-tops-revenue-estimates/ar-AA22yPNr?ocid=BingNewsVerp", "source_name": "MSN", "published_at": "2026-06-11T18:39:45", "published_display": "11 Jun 2026 18:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Understanding Momentum Shifts in (LFMDP)", "summary": "This article provides an in-depth analysis of Lifemd Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (NASDAQ: LFMDP), highlighting a neutral sentiment across all time horizons. It presents three distinct AI-generated trading strategies\u2014position trading, momentum breakou", "url": "https://news.stocktradersdaily.com/news_release/1/Understanding_Momentum_Shifts_in_LFMDP_061026032002_1781119202.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-10T15:20:00", "published_display": "10 Jun 2026 15:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD: A Growing Healthcare Tech Stock, As Q1 Results Confirm Patient Demand", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPYjZTemNEbEdKQ0ZmOE1TaFE5bTFReUV5SmlPazBuZUZGdHVGLW41ZTBvMHE4cDVPRFZyVFEwMGItN2ppMkhFWUVnZ2xsQjRvamRaVjFOSE80NlMyNGlyaVdXc0xFQmVicG5YbkJuUUhiN3hqQW50bVVVYWJFckY1WGNjaF9rR1B4TVluNzNJc3pwUUZWdVBucEIxb1czaGZWeGFtNy0tUjlvM1Vpa2J6YU5KZnM3dTJsNHpmUQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Story Is Evolving For LifeMD (LFMD) With An Unchanged Fair Value View", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQbm5aTEdkWUlhT3ZkbXh0SGpxZVV6MEZ5ZlZiTWRmR2d3RDk2ZGpJWDBSeXhDWXNSY0ktSnBoc1JUUnlJWVUxbVM3anhEVERud01uc200aFZvU0xWQU9lem8tQmZnUnZiRU1GenI3Zlg5WVdjcWlENVV5azVwR0pjLUVCV1RQYzBjOEktLXY4NWNwNENPcEI2R3haaWJGNG9mOG9J?oc=5", "source_name": "Market source", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD (LFMD) CTO Sripad Umesh submits initial Form 3 filing", "summary": "LifeMD, Inc.'s Chief Technology Officer, Sripad Umesh, has submitted his initial Form 3 filing, an SEC document reporting beneficial ownership of securities. The filing identifies Umesh as an officer but not a ten percent owner of the company, and it states that there were no sha", "url": "https://www.stocktitan.net/sec-filings/LFMD/form-3-life-md-inc-initial-statement-of-beneficial-ownership-f23d6fe6bd3f.html", "source_name": "Stock Titan", "published_at": "2026-06-04T01:40:17", "published_display": "04 Jun 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD (LFMD) CTO receives 75,000-share time-vested stock grant", "summary": "LifeMD, Inc.'s Chief Technology Officer, Sripad Umesh, received a grant of 75,000 shares of common stock as compensation, indicating a neutral impact and sentiment. These shares are restricted stock units that will vest in three installments over three years: 25,000 units on June", "url": "https://www.stocktitan.net/sec-filings/LFMD/form-4-life-md-inc-insider-trading-activity-e55ab58d4586.html", "source_name": "Stock Titan", "published_at": "2026-06-04T01:40:17", "published_display": "04 Jun 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Press Release: LifeMD Appoints Umesh Sripad as Chief Technology Officer", "summary": "LifeMD has announced the appointment of Umesh Sripad as its new Chief Technology Officer. Sripad brings extensive experience from his previous executive roles at companies like Best Buy and Amazon, where he led significant technological advancements and strategic initiatives. His", "url": "https://www.moomoo.com/hans/news/post/70862237/press-release-lifemd-appoints-umesh-sripad-as-chief-technology-officer", "source_name": "Moomoo", "published_at": "2026-06-02T03:39:39", "published_display": "02 Jun 2026 03:39", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD Appoints Umesh Sripad as Chief Technology Officer", "summary": "LifeMD, Inc. has appointed Umesh Sripad as its new Chief Technology Officer, effective immediately. Mr. Sripad brings over two decades of experience in digital transformation and will be responsible for leading LifeMD's technology strategy, AI enablement, cybersecurity, and scala", "url": "https://www.globenewswire.com/news-release/2026/06/01/3304337/6480/en/lifemd-appoints-umesh-sripad-as-chief-technology-officer.html", "source_name": "GlobeNewswire", "published_at": "2026-06-02T02:40:17", "published_display": "02 Jun 2026 02:40", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD Names Umesh Sripad as Chief Technology Officer", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/lifemd-names-umesh-sripad-chief-132319380.html", "source_name": "MT Newswires", "published_at": "2026-06-01T13:23:19+00:00", "published_display": "01 Jun 2026 13:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ex-IKEA digital chief to lead AI, cybersecurity at telehealth LifeMD", "summary": "LifeMD (Nasdaq: LFMD) has appointed Umesh Sripad as Chief Technology Officer to spearhead the company's technology strategy, AI initiatives, cybersecurity, and data infrastructure as it expands its direct-to-patient telehealth platform. Sripad, who previously held leadership role", "url": "https://www.stocktitan.net/news/LFMD/life-md-appoints-umesh-sripad-as-chief-technology-wxsplvc3kmdo.html", "source_name": "Stock Titan", "published_at": "2026-06-01T12:09:51", "published_display": "01 Jun 2026 12:09", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD to Participate in Upcoming Investor Conferences", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/lifemd-participate-upcoming-investor-conferences-120000967.html", "source_name": "GlobeNewswire", "published_at": "2026-05-15T12:00:00+00:00", "published_display": "15 May 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD, Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/41e181b8-b18a-3255-9720-0df6d7bd192b/lifemd%2C-inc.-q1-2026-earnings.html", "source_name": "Moby", "published_at": "2026-05-07T12:30:00+00:00", "published_display": "07 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD Q1 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/13172cbc-f2ee-3d92-be99-a212f1217b26/lifemd-q1-earnings-call.html", "source_name": "MarketBeat", "published_at": "2026-05-07T02:16:46+00:00", "published_display": "07 May 2026 02:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD adds 42,000 subscribers; women\u2019s sign-ups jump 657%", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxOenBXcjRsOFI3WEJOWGZ6WGZZZXFSX29GY0w5ajlnc3EtNHQ0SzNsRFVMeGc1cUx5V25WTmVqcE9xbzNoTmJGVkZNbElyYTdFRy1NWU91Snh0a3BxbjdDeklFU183TXlHZ2pvWnlXczFRLWlDaWRfdDVBdW5oN2h6NTZ0OTFoamhCMnl2WDlNZTZMWWM?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The LifeMD (LFMD) Story Is Shifting Around GLP-1 Growth And 2026 Expectations", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQazhpZlNhSjNqaU9LeFd4b251S1lOOGtRc3RuVEUwN1NRM0liNnh2YTdyNU9jREp5T0p6S29UWTVFTFFwRlVLNmNSSkFXOVZpUjNhWVJldFRzNjlaZ1VTeUpLRWZIWWdEY3huQ015dnUyWDdjUXhWZ1RZRzQ5cUFLYUxRaXhNVEszTTZqc1RMTWVqWnVaM2xRcmFvTVFMY0E?oc=5", "source_name": "Market source", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "After the bell May 6: LifeMD sets Q1 results call for 4:30 p.m. ET", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQWnlfSTBIUFdzT0lpbUwtcmU3WTdTa0NXZjZCSEdWWmtlYll3ZGRITDZxNVdqMDdCX052cHV1V2hHOWE1T19lLUFHdE9nVzJ1TnhDY09BdFd6WGlmQVBSSE5nQzhpa1NacDBSWDdYVGNxZzZuakxGc0d0SGllRUZ1QkQyQUpudzJjem9nTGdWcGQ2M1VzTGJ1ZFRGM3lVcjdROXcyRWVpbHFWd2V6LS1oUEVGbHozd2c?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD (LFMD) Soars 23.7%: Is Further Upside Left in the Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNdVowRzMxQW5hTDBWRV9xUEZWemRsV2Vsc0xPSTZvcVRTWlBVOFE0ZE9hb25oeERJclpaRkZDQmpFMmN5dmFUd2tSYjQ3VVVCZUJvVy1UZEFiOHUzX2VUajk0TUhzSlZZeURVb0FUenFuVmNjWGQ1UEFJeksyajQ2aDRUSTRxUEI0Y0lMU0RLVUM?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The LifeMD (LFMD) Story Is Shifting Around GLP-1 Growth Plans And 2026 Expectations", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQcXNWV0VIekNnVTllc2hBU2xOUHdsTDdmR3dFWC1aTVhxN0FKNTIxNkRJWmRUS3h6WUs0OEY0OTNoWVhoTDNJYjBnNFlYX2hzSkxLSVVnbWpyLU4yeHdBQkhOR1YxZmNBTld0T2hZOHRCbnJrMjk0WDlQSVVRX0hHaVFuOUhyZ3o3ZzZlUUc4Rm9hUElVME1INmpuMlpOTzQ?oc=5", "source_name": "Market source", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The LifeMD (LFMD) Story Is Shifting On GLP\u20111 Growth And Higher 2026 Targets", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxORHdYU0hydjJrdTNxMVdTSTcwVW9TbHVxdDc1Y005UlZPdHcxUy1QTjJzQkx4M2VxQ3Z4TVQ1a3Fwdm1PUW5ZOWEzUm9uRlhVUjdjZ1hLYmlaR0lNdlhYMDRXdVZhMUNnVGJkTUdJUzNmcHBiLTQwbDVKWk53QWVnSzk1d1NLbXREUlBjZUFWOVB0RFhieG5zdUxPNA?oc=5", "source_name": "Market source", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD (LFMD) Is Up 32.7% After Returning To Profitability And Expanding GLP\u20111 Telehealth Offerings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-14T07:00:00+00:00", "published_display": "14 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At LifeMD (LFMD) Valuation After Profitability Return And 2026 Growth Guidance", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxPZG13a05hTWJpZ0Y0dk5Wa2tjNWMtaXhCQlFOckEzZi1PaVF6TThGSG9xVElyZVY4Z2J6VERPMGpyZWpyaS1LLUpFUzRqQ1JycjBvVHJXVEhzRHdqbWhHWXFRMGFXY3dlZGlBa2gzUGx1VzRkdFFXRVBFSE9oSGRRMjdlR1Ixb2pRNFBkV2Yzaw?oc=5", "source_name": "Market source", "published_at": "2026-03-13T07:00:00+00:00", "published_display": "13 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD (LFMD) Valuation Check After Earnings Beat Guidance Update And Wegovy Partnership", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD (LFMD) Trailing Losses Narrow To US$14.6m Challenging Bearish Profitability Narratives", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQLXotd0Z4SWRLQ2ptdHFCVnZMaGdlTTN4TjhhMktEWkswYU1PMm9lekF4ZklMR0RtenhUY3owaDhXazZGSGJrOFhzbFhqNks5Y2FQNVdybmJ5akMxS1pWdF9ncm5MTHZqNXRYOVRtSE5BbFRKTFZhdGN5Ti1zRDlxcmdNdlVMMzRhM2VBYkEzUlY0OEFOMXU0VXJqY3NXbDRnNURmeFVpQU5lelh4UkEzN0c1dkdlNWs0a2VHaVhGaHVQdzRTUkHSAcsBQVVfeXFMTVJSS2paNUl3VmJYNG1RNjYwb0ZhdW5mampZM0gwWnJxNF9FSEpuY2k3ZERLQTQ0dDdrY3VfWGE0c2hSV2VkdEMxVzFhbDVwcDNXc0gwTExvbFNjV3lfZXNxM1puOERlc3plMG1yWExQZ3k0cm05bHJJMjg5dXlwZE83S0h5aTBHcWR2dmhCNk03SVViSUtVVWxqOVVoYmx5c0ptZjBlWXQ1Z0NHNUJfM0pQVk11SkpkbUR3OXI2VXA0bHdyUmp1aEhKd1k?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What Do LifeMD's Q4 2025 Results Really Tell Us", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxPamJtaUgyZ3FlZU5qQXJzYTBVQlZ6cXBXdzRxZTlzeEhjQmRvZ1lka3MtcUUwc1Z2R3lxZHFSWEZrRmdPM0dCdUhJOWxQb0hHLWs3MG1qS3lERTRkTUNVbHpJalJscEl6Ullqcm5uU2lxdW1xb1E2Mnp2cmI3NUVaS1Q1cWhrWXBTR3c?oc=5", "source_name": "Kavout | AI", "published_at": "2026-03-09T07:00:00+00:00", "published_display": "09 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIFEMD ($LFMD) Releases Q4 2025 Earnings, Stock Rises | LFMD Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNTHNsRmxiWTBmTmlVRkJKd0pvbVM2ZnZneExZdEZSbXRuLVl3Vml5NExqdndUTmtfd29DTU5USWZiMkZrTFdtUjdOSTBzcWVLbDRLOTRMOWJhVzQ1dDJURl91YmdBQ3lXTDc1eUg1R0VSMFdWa2tkSHVzempIUG5iRVY3OEdmeEZ0TURvYjJmM045azJsUWUyZUd3?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-03-09T07:00:00+00:00", "published_display": "09 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD, Inc. (LFMD) Reports Q4 Loss, Tops Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE43dTRFcjlVQ2pCYUJNS05MZlN3aV96clA1dzB4WXhuNkVRUHpiYUFYa0ZOV2l3QWZfUlNZQ2J2dzFTem1XYXROUDdIVW1Qek5MbTNWeGNka1hSVnlBUGVFLU5BTG56alBORzBkbm1hbi1aSjhNRHRLRmdBSEc?oc=5", "source_name": "Market source", "published_at": "2026-03-09T07:00:00+00:00", "published_display": "09 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Investors Shouldn't Be Surprised By LifeMD, Inc.'s (NASDAQ:LFMD) 31% Share Price Plunge", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-12T08:00:00+00:00", "published_display": "12 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD, Inc. Common Stock (LFMD) Stock Price Today & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE9hWHdDM2ZjSWJfM0JYTzZ1LTlMUkJaZWRRd0NGNG40Vl9pcEFfd3RKZGVGeXN2bWxmeGMtanNzQmlsaW1Ub2FCQU4zWFpQaEFMSzdnY3h2OA?oc=5", "source_name": "Gotrade", "published_at": "2026-01-13T02:37:55+00:00", "published_display": "13 Jan 2026 02:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why LifeMD (LFMD) Is Up 15.2% After Securing Credit Line And Adding Oral Wegovy Access", "summary": "", "url": "https://news.google.com/rss/articles/CBMidEFVX3lxTE1rcUt0R1V0Q0ZidGJFWHFFY2RrR1VuaUFKQnk0M25XM2dkSW1fajZDNmxqUXlweFVvWDdWVl9FZlRrblR4R1BFSm95NmxUSGdqeG5EUFdUUUpmUGcxUTV3YnZBVThtQ1lTUXR5R2lIU0o1YUM3?oc=5", "source_name": "Market source", "published_at": "2026-01-08T08:00:00+00:00", "published_display": "08 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD (LFMD): Valuation in Focus After Earnings Miss, Guidance Cut, and Telehealth Shift", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxPVy1fXzJCakcxMlRKcl9sQndHZkRzcFVlejJQMURiVEtUeEhyb1dBWk9vOVB0VWxYcGlBTHU2LTZUcHZrQUtHQkx5V003TFhpWlZvOWVBdGxXcFZyWG54UFVNaFB5SGc3b1pPNTVObzI4emFXZHhRWW9XU3h2Y1BQeU9pU1lMLXdZbGc?oc=5", "source_name": "Market source", "published_at": "2025-11-20T08:00:00+00:00", "published_display": "20 Nov 2025 08:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD, Inc.'s (NASDAQ:LFMD) Path To Profitability", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-10-11T07:00:00+00:00", "published_display": "11 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Insider Has Just Sold Shares In LifeMD", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-09-15T07:00:00+00:00", "published_display": "15 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LifeMD, Inc.'s (NASDAQ:LFMD) market cap dropped US$56m last week; individual investors who hold 44% were hit as were institutions", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-07-12T07:00:00+00:00", "published_display": "12 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 94, "total_relevant": 50, "sentiment_summary": {"positive": 17, "negative": 5, "neutral": 28, "score": 56, "total": 50, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 81, "events": [{"event": "general", "label": "Market update", "weight": 16.5, "count": 30}, {"event": "earnings", "label": "Earnings", "weight": 6.95, "count": 12}, {"event": "capital_return", "label": "Capital return", "weight": 1.65, "count": 3}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 17, "negative_events": 5}, "market_context": {"has_market_context": true, "latest_close": 4.64, "latest_week": "2026-07-10", "one_week_move": -4.7, "four_week_move": -1.3, "twelve_week_move": 13.4, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.762311, "market_dynamics_buy_signal": false, "relative_strength": -19.734618, "fair_value_gap": -25.7, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 47.1766, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-4.7% over one week, -1.3% over four weeks, trend active, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 66, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 11}, {"label": "Stock Titan", "count": 8}, {"label": "simplywall.st", "count": 7}, {"label": "TradingView", "count": 5}, {"label": "GlobeNewswire", "count": 3}, {"label": "TradingKey", "count": 2}, {"label": "Nasdaq", "count": 1}, {"label": "Investing.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 50}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 30}, {"label": "Earnings", "count": 12}, {"label": "Capital return", "count": 3}, {"label": "Deals and strategy", "count": 1}, {"label": "Analyst action", "count": 1}, {"label": "Regulatory and legal", "count": 1}, {"label": "Guidance", "count": 1}, {"label": "Balance sheet", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "56/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "81/100 classification confidence."}, {"label": "Company focus", "value": "50", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-4.7% over one week, -1.3% over four weeks, trend active, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "LifeMD Rings the Nasdaq Stock Market Closing Bell"}], "updated_at": "2026-07-16T08:08:48.338153+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}